Triangle Clinical Research International is categorized under Medical Labs in Chapel Hill, NC and active since 2007.
Triangle Clinical Research International was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact William G Elmore Jr at the company’s single location by writing to 102 Telluride Trail, Chapel Hill, North Carolina NC 27514 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Triangle Clinical Research International |
| Contact Person: | William G Elmore Jr |
| Address: | 102 Telluride Trail, Chapel Hill, North Carolina 27514 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Triangle Clinical Research International was started in 2007 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact William G Elmore Jr for inquiries that concern Triangle Clinical Research International by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Triangle Clinical Research International can be found at the coordinates as well as the street address 102 Telluride Trail in Chapel Hill, North Carolina 27514.
For its online presence, you may visit Triangle Clinical Research International’s website at and engage with its social media outlets through on Twitter and on Facebook.